These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4989295)

  • 1. 5(or 4)-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4(or 5)-carboxamide (NSC-82196): microbiologic evaluation and assay.
    Pittillo RF; Hunt DE
    Cancer Chemother Rep; 1967 Aug; 51(4):213-23. PubMed ID: 4989295
    [No Abstract]   [Full Text] [Related]  

  • 2. Adaptation of a colorimetric determination of 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (NSC-45388) and 5-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196) to blood.
    Field RB; Hoffman G; Waravdekar VS; Kline I
    Cancer Chemother Rep; 1969 Jun; 53(3):199-202. PubMed ID: 4980814
    [No Abstract]   [Full Text] [Related]  

  • 3. 5(or 4)-(3,3-dimethyl-1-triazeno)imidazole-4(or 5)-carboxamide (NSC-45388): microbiologic assay in mouse tissues.
    Hunt DE; Pittillo RF
    Cancer Chemother Rep; 1968 Sep; 52(5):553-6. PubMed ID: 4914917
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness of antileukemic agents in mice inoculated with leukemia L1210 variants resistant to 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) or 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196).
    Kline I; Woodman RJ; Gang M; Venditti JM
    Cancer Chemother Rep; 1971 Feb; 55(1):9-28. PubMed ID: 5121657
    [No Abstract]   [Full Text] [Related]  

  • 5. Kinetics of the effect of 5(or 4)-(3,3-dimethyl-1-triazeno)-imidazole-4 (or 5) -carboxamide (NSC-45388) and 5(or 4)-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4(or 5)-carboxamide (NSC-82196) on the reproductive integrity of cultured leukemia L1210 cells.
    Wilkoff LJ; Dulmadge EA; Dixon GJ
    Cancer Chemother Rep; 1968 Dec; 52(7):725-32. PubMed ID: 5754670
    [No Abstract]   [Full Text] [Related]  

  • 6. Value of cytosine arabinoside (NSC-63878) plus 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) therapy in advanced murine L1210 leukemia and enhancement of the combination with sequential doses of methotrexate (NSC-740) or 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).
    Kline I; Woodman RJ; Gang M; Cysyk RL; Venditti JM
    Cancer Chemother Rep; 1973; 57(3):291-8. PubMed ID: 4751255
    [No Abstract]   [Full Text] [Related]  

  • 7. The physiological disposition of the carcinostatic imidazole-4 (or 5)-carboxamide, 5(or 4)-[3,3-bis(2-chloroethyl)-1-triazeno] (NSC 82196) (imidazole mustard) in mice and dogs.
    Vogel CL; Denham C; Waalkes TP; DeVita VT
    Cancer Res; 1970 Jun; 30(6):1651-7. PubMed ID: 5457935
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the cytotoxicity of 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) on normal and leukemic colony-forming cells.
    Valeriote F; Tolen S
    Cancer Chemother Rep; 1971 Feb; 55(1):43-6. PubMed ID: 5121649
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolism of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in human and animal tumor tissue.
    Mizuno NS; Humphrey EW
    Cancer Chemother Rep; 1972 Aug; 56(4):465-72. PubMed ID: 5081589
    [No Abstract]   [Full Text] [Related]  

  • 10. 5-Fluorouracil (5-Fu; NSC-19893), 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388), vincristine (NSC-67574), and 1,3-bis(2-chloroethyl)-2-nitrosourea (BCNU; NSC-409962) given concomitantly in the treatment of solid tumors in man.
    van Eden EB; Falkson G; van Dyk JJ; van der Merwe AM; Falkson HC
    Cancer Chemother Rep; 1972 Feb; 56(1):107-47. PubMed ID: 5030803
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanism of action of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide in mammalian cells in culture.
    Gerulath AH; Loo TL
    Biochem Pharmacol; 1972 Sep; 21(17):2335-43. PubMed ID: 4675028
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical experience with 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) in the treatment of metastatic malignant melanoma.
    Falkson G; Van der Merwe AM; Falkson HC
    Cancer Chemother Rep; 1972 Oct; 56(5):671-7. PubMed ID: 4569061
    [No Abstract]   [Full Text] [Related]  

  • 13. 5(or 4)-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4(or 5)-carboxamide (NSC-82196)--clinical brochure.
    Carter SK; Newman JW
    Cancer Chemother Rep 3; 1968 Dec; 1(1):63-80. PubMed ID: 4989815
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of treatment schedules and route of administration on the chemotherapy of murine leukemia L1210 with 5(or 4)-[3,3-bis( 2-chloroethyl)-1-triazeno]imidazole-4(or 5)-carboxamide (NSC-82196).
    Hoffman G; Kline I; Gang M; Tyrer DD; Venditti JM; Goldin A
    Cancer Chemother Rep; 1968 Dec; 52(7):715-24. PubMed ID: 5743709
    [No Abstract]   [Full Text] [Related]  

  • 15. Fate of the ring moiety of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide in mammalian cells.
    Saunders PP; Chao LY
    Cancer Res; 1974 Oct; 34(10):2464-9. PubMed ID: 4472112
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II study of 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) in advanced gastrointestinal cancer.
    Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
    Cancer Chemother Rep; 1972 Apr; 56(2):267-9. PubMed ID: 5043230
    [No Abstract]   [Full Text] [Related]  

  • 17. Disposition of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide, a new antitumor agent.
    Housholder GE; Loo TL
    J Pharmacol Exp Ther; 1971 Nov; 179(2):386-95. PubMed ID: 5133607
    [No Abstract]   [Full Text] [Related]  

  • 18. Imidazole carboxamides: relationship of lipophilicity to activity against intracerebral murine glioma 26 and preliminary phase II clinical trial of 5-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196) in primary and secondary brain tumors.
    Levin VA; Crafts D; Wilson CB; Kabra P; Hansch C; Boldrey E; Enot J; Neely M
    Cancer Chemother Rep; 1975; 59(2 Pt 1):327-31. PubMed ID: 1149010
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolism of 4(5)-(3,3-dimethyl-1-triazeno)-imidazole-5(4)-carboxamide to 4(5)-aminoimidazole-5(4)-carboxamide in man.
    Skibba JL; Ramirez G; Beal DD; Bryan GT
    Biochem Pharmacol; 1970 Jun; 19(6):2043-51. PubMed ID: 5513972
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the fungistatic and barteriostatic properties of 4 new substance classes from isothiocyanates and N,N-bis-(2-chloroethyl)-amine].
    Weuffen W; Dorn H
    Pharmazie; 1967 Oct; 22(10):580-3. PubMed ID: 4971605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.